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ABSTRACT 10 
Chemicals’ half-lives derived from biotransformation simulation studies are central metrics 11 
for persistence assessment in international regulatory frameworks. To determine persistence 12 
of chemicals released to the aquatic environment, paradigm shifts in recent and on-going 13 
revisions of chemical legislations assign increasing importance to OECD 309 simulation 14 
studies. OECD 309 studies were designed to target biotransformation in natural water (pelagic 15 
test) or in water amended with sediment (suspension test). The suspension test bears several 16 
advantages over the pelagic test - most importantly, it employs higher bacterial cell densities, 17 
which promote biotransformation of various chemicals at observable rates. Yet, experience 18 
with suspension tests is limited. In this study, we followed the fate of 43 pharmaceuticals, 19 
pesticides, and industrial chemicals in various suspension test setups and elucidated 20 
parameters influencing biotransformation kinetics and half-lives derived thereof. Besides 21 
striking intra-study variability between replicates, we found that differences in sediment 22 
origin and bacterial cell density resulted in chemical half-lives with up to two orders of 23 
magnitude difference, making persistence classification rather uncertain. Yet, data suggested 24 
that test systems employing bacterial cell densities at a relatively steady state close to the 25 
upper limit of what is commonly observed in natural surface waters yielded increased and 26 
more uniform biotransformation of chemicals. 27 
  28 
INTRODUCTION 29 
Chemicals can enter surface water bodies through various pathways where they bear the 30 
potential to harm aquatic ecosystems. Actual concentration levels of chemicals in surface 31 
waters depend on their environmental persistence, defined by a chemical’s recalcitrance 32 
towards biotic and abiotic transformation [1-3]. In recent years, chemicals’ half-lives as 33 
indicators of their persistence are becoming increasingly central metrics for hazard and risk 34 
assessment in international regulatory frameworks [1, 3-5].  35 
The OECD has developed a series of test guidelines used by professionals involved in 36 
chemical persistence assessment and accepted by international regulatory frameworks, e.g., 37 
by the REACH regulation of the European Union [1, 6]. Two test guidelines are relevant for 38 
chemicals that may enter surface waters: the OECD 308 guideline, which targets 39 
biotransformation in aquatic sediments, and the OECD 309 guideline, which assesses 40 
biotransformation in the pelagic water body [7, 8].  41 
In November 2018, the European Medicines Agency (EMA) released a draft revision of their 42 
environmental risk assessment guidelines for marketing authorization of pharmaceuticals, 43 
whose review and revision process is on-going. A major paradigm shift in the new draft 44 
guideline is that OECD 309 rather than OECD 308 tests may become the cornerstone of 45 
persistence assessment for pharmaceuticals [9, 10]. The draft guideline thus follows REACH 46 
regulations, which also emphasize using OECD 309 tests to assess persistence of industrial 47 
chemicals [11].  48 
The OECD 309 guideline allows two experimental setups, i.e., testing biotransformation in 49 
natural water (pelagic test) or in water amended with sediment to a concentration of up to 1 g 50 
solids L-1 (suspension test) [8]. To date, OECD 309 studies are mostly carried out as pelagic 51 
tests. Pelagic tests pass the validity criteria described in the current OECD 309 guideline 52 
when the examined water contains biomass concentrations of minimally 103 to 104 cells mL-1 53 
[8]. However, in fact, bacterial cell densities are higher in most natural surface waters ranging 54 
from 104 to 107 cells mL-1, with a global average of 106 cells mL-1 [12-15]. Low biomass 55 
concentrations in pelagic tests - which are nevertheless deemed to be valid - lead to the effect 56 
that very low levels of biotransformation are observed for a large majority of substances and 57 
potentially biodegradable compounds may be assessed as persistent. In case a compound is 58 
actually biotransformed in a pelagic test - despite the low levels of degrader biomass provided 59 
- variability amongst studies with different water samples is high [16, 17]. Previous pelagic 60 
tests revealed up to 20-fold differences in half-lives of certain substances, depending on the 61 
origin of employed waters [16, 17].  62 
Increasing inoculum concentrations by adding sediment-borne biomass may therefore 63 
increase the environmental relevance of OECD 309 studies. Furthermore, previous research 64 
suggests that increased degrader biomass and pre-exposure of microbial communities to 65 
chemicals support their biotransformation, reduce lag phases, and increase reproducibility of 66 
laboratory tests [16-23]. However, to the best of our knowledge, so far only a limited number 67 
of studies assessed biotransformation of chemicals in water-sediment suspensions and the 68 
chemicals were limited to only few model compounds [24-26]. Moreover, these studies did 69 
not investigate the influence of bacterial cell densities on biotransformation kinetics, nor did 70 
they provide general conclusions on the reproducibility and comparability of suspension tests 71 
when conducted in water and sediment sourced from different locations.  72 
Therefore, we here explored biotransformation behavior of 43 pharmaceuticals, pesticides, 73 
and industrial chemicals that are ubiquitously present in wastewater treatment plant effluents 74 
and surface waters [27-31], and hence are environmentally relevant, in various suspension 75 
tests, and gathered consistently derived persistence information. To study the effect of testing 76 
different microbial communities with varying bacterial cell densities, our experiments were 77 
conducted in suspensions sampled from an agriculture- and wastewater effluent-impacted 78 
river and a pristine pond at two sediment concentrations, one of them within and one beyond 79 
OECD 309 standards. From this, we elucidated experimental parameters that generally 80 
influence biotransformation in laboratory experiments across a wide range of chemicals. We 81 
hereby aim to support the on-going EMA revision process with timely experimental evidence 82 
on the suspension test of the OECD 309 guideline, which will likely gain significant 83 
importance for persistence assessment across relevant regulatory frameworks for various 84 
chemicals [9, 11].   85 
 86 
MATERIALS AND METHODS  87 
Detailed information on laboratory methods and data analysis are provided in the Supporting 88 
Information (SI1, SI2). In brief, suspensions containing 1 and 10 g solids L-1 were prepared 89 
with water and sediment sampled from the Rhine (R, Mumpf, Switzerland) and from 90 
Cressbrook Mill Pond (CMP, Derbyshire, UK). Suspensions are referred to with a code 91 
indicating sampling site, sediment concentration in g L-1, and sampling time in case of Rhine 92 
suspensions. The lower biomass suspensions are R1-Fall, R1-Spring, and CMP1, the higher 93 
biomass suspensions are R10-Fall, and CMP10. Sampling of the Rhine was done twice, i.e., 94 
in fall and in spring, to obtain environmental samples with comparable physicochemical 95 
properties (Table SI2) but different microbial communities. This investigation of seasonality 96 
was done in 1 g solids L-1 suspensions to be consistent with current OECD 309 standards. 97 
Sediment was kept in suspension via orbital shaker and additionally via magnetic stirrer in 98 
case of CMP sediment (CMP1-Stirrer/ CMP10-Stirrer). Sterile hydrolysis and sorption 99 
experiments were conducted alongside the respective biotransformation experiments to 100 
distinguish compound removal via biotransformation from abiotic transformation or phase 101 
transfer.  102 
Test systems were spiked with a mixture of 43 test compounds to a concentration of 1 µg L-1 103 
each. Dissipation of the parent compound was monitored by analyzing up to 11 subsamples 104 
taken from the water phase of each experimental vessel over a time course of more than 54 105 
days. Chemical analysis was performed on an Agilent Triple Quad MS coupled to a HPLC 106 
system.  107 
Total parent compound residues in experimental systems at a given time were calculated from 108 
measured water phase concentrations, considering a sediment-water partitioning coefficient 109 
derived from sorption experiments. Compound residues in each experimental replicate as a 110 
function of time were fitted to a first-order degradation model considering lag phases to be 111 
consistent with data evaluation recommendations in regulatory frameworks [8, 32]. Here, we 112 
defined the total system degradation half-life (DegT50,TS) as the time interval needed to reach 113 
50% primary degradation, once compound dissipation has started. In contrast, the total system 114 
dissipation half-life (DT50,TS) was defined as the sum of DegT50,TS and the length of the lag 115 
phase.  116 
Bacterial cell densities were determined by sacrificing whole experimental vessels at various 117 
time points and enumerating cells, both in the water phase and in the bulk sediment, by using 118 
a BD Accuri C6 Flow Cytometer. Due to the necessity of sacrificial sampling, 119 
biotransformation experiments were performed with up to 18 replicates and chemical 120 
trajectories end at different time points. Still, chemicals’ dissipation was monitored in at least 121 
two replicates up until the end of each experiment.  122 
 123 
RESULTS AND DISCUSSION 124 
Biotransformation in suspension tests. Biotransformation was distinguished from 125 
hydrolysis and sorption by comparing biotransformation experiments with their abiotic 126 
controls (SI2.2). In agreement with Shrestha et al. [24], results of CMP1/10-Stirrer revealed 127 
that keeping sediment in suspension via magnetic stirrer led to grinding of particles and 128 
continuously increased sorption of chemicals, which made differentiation between 129 
transformation and phase transfer difficult (SI5). Therefore, data from stirrer experiments was 130 
not used further. Based on biotic and abiotic experiments using the orbital shaker instead, 131 
dissipation of 35 compounds could be assigned at least partially to biotransformation. 132 
Concentration-time series obtained for those compounds are shown in Figure SI1. 133 
Generally, compound dissipation via biotransformation was faster in suspensions with 134 
increased sediment content. Least compound losses were observed in CMP1 and R1-Fall - 135 
only six substances showed up to 50% removal by the end of those experiments - while 136 
dissipation of most substances could be observed in R10-Fall and CMP10. Correspondingly, 137 
bacterial cell densities were lowest in CMP1 and R1-Fall with an average of 5x106 and 138 
1.6x107 cells mL-1, respectively. As increasing sediment content led to increased sediment-139 
borne biomass, higher average cell densities of 4x107 and 3.2x107 cells mL-1  were measured 140 
in R10-Fall and CMP10, respectively. In R1-Spring, we measured an average of 2.2x107 cells 141 
L-1, meaning that cell densities did not differ strongly between R1-Fall and R1-Spring. 142 
Strikingly though, most compounds dissipated much faster from various replicates of R1-143 
Spring compared to R1-Fall. This suggests that the extent of compound removal via 144 
biotransformation is influenced by bacterial cell densities, but also by the composition or 145 
activity of the microbial test communities. The latter two parameters have been demonstrated 146 
to undergo seasonal variations in surface waters [33-35], which agrees with our findings of 147 
varying biotransformation capacities in environmental samples sourced during different 148 
seasons.  149 
Besides inter-study variations, we observed drastic differences between replicates of the same 150 
study once biotransformation of compounds reached a detectable range. We expressed intra-151 
study variations as the spread between maximum and minimum concentrations of one 152 
compound in different replicates at the same time point. Especially during R1-Spring and 153 
R10-Fall, intra-study variations increased over time; in R1-Spring, the average spread 154 
between trajectories increased from 270 ng L-1 after 13 days to 430 ng L-1 after 28 days. Intra-155 
study variations in biotransformation kinetics were lowest in CMP10 with a spread of less 156 
than 90 ng L-1 regardless of the time point. Described inter- and intra-study variations are 157 
exemplarily illustrated for the three compounds atenolol, carbendazim, and diuron in Figure 1.  158 
 159 
Figure 1. Concentrations of atenolol, carbendazim, and diuron measured in the water phase of 160 
R1-Spring, R1-Fall, R10-Fall, CMP1, and CMP10. Suspensions containing 1 g solids L-1 are 161 
colored in grey with measured data represented as diamonds, and suspensions containing 10 g 162 
solids L-1 are shown in red with measured data represented as squares. Measurement points 163 
belonging to the same experimental replicate are connected with dashed lines. The solid line 164 
shows the average concentration calculated from the plotted experimental replicates, shaded 165 
areas indicate the spread of the concentrations measured at the same time point.  166 
 167 
Interestingly, the extent of variations in biotransformation kinetics coincide with the extent of 168 
variations in bacterial cell densities. These variations, expressed as coefficient of variation 169 
(CV) calculated from flow cytometry measurements in sacrificed replicates, were greatest in 170 
R1-Spring and R10-Fall, with CVs of 74 and 84%, respectively, and lowest in CMP10 with a 171 
CV of 44% (SI6, Figure SI4). If we assume that different densities in different replicates at 172 
different time points could be considered an approximate indicator of the extent of community 173 
dynamics during the experiments, our data suggests that larger community dynamics 174 
coincides with increased intra-study variabilities. However, we acknowledge that this 175 
hypothesized relationship would certainly profit from actual time series obtained from 176 
individual experimental vessels, and additional analysis of not only cell densities but also 177 
microbial community composition and activity.  178 
Generally, little variation was observed for rapidly degrading compounds, i.e., atenolol, 179 
bezafibrate, and fenoxycarb. Literature suggests that those compounds are biotransformed by 180 
enzymes widespread among bacteria [36-39], supporting our observation that 181 
biotransformation readily occurred in different suspension tests; atenolol was also found to be 182 
degradable in OECD 309 pelagic tests [16]. However, inter- and intra-study variations in 183 
chemical removal indicate that most of our test compounds seem to have been transformed by 184 
enzymes less widespread or only expressed under specific conditions. Rare enzymes have a 185 
lower probability of occurrence at lower inoculum concentrations and their emergence in 186 
different test systems strongly depends on how the microbial community evolves over time 187 
[19, 39-41]. Coherently, a previous study in activated sludge showed that biotransformation of 188 
acesulfame, phenylureas (i.e., diuron and isoproturon in our study), and carbendazim strongly 189 
depends on the solids retention time and hence community composition, suggesting a need for 190 
enzyme activities not always present in activated sludge [36]. In our study, inoculum 191 
concentrations above 107 cells mL-1 were required to increase the likelihood of providing 192 
sufficient specific degraders/ enzymes to yield observable dissipation of most compounds 193 
from water-sediment suspensions. Qualitatively aligned with our findings, a recently 194 
conducted international ring test showed that increasing cell densities in biodegradation tests 195 
with marine waters (OECD 306 [42]) from 105  to 107 cells mL-1 [43] allowed for less variable 196 
characterization of biotransformation of five test compounds. With our much broader set of 197 
compounds, we showed that elevating inoculum concentrations to the upper limit of what is 198 
commonly observed in natural surface waters [15] increased the probability to trigger 199 
biotransformation reactions; however, significant inter- and intra-study variations could still 200 
occur.  201 
Besides the need for emergence of specific enzymes to remove the majority of our test 202 
compounds from aquatic systems, co-metabolic processes might also have promoted 203 
compound dissipation during our suspension tests [17, 39, 44]. When comparing suspension 204 
tests employing bacterial cell densities sufficient to trigger compound removal via 205 
biotransformation (i.e., R1-Spring, R10-Fall, and CMP10), we found shortest lag phases and 206 
most uniform dissipation in CMP10. Since average cell densities, at least between R10-Fall 207 
and CMP10, did not differ much, we speculate that the comparably elevated carbon and 208 
nutrient availability in CMP10 suspensions (Table SI5) might have led to a generally more 209 
active microbial community and increased co-metabolism of our test compounds.  210 
Suspension tests in a regulatory context. To further reflect how observed varying 211 
biotransformation capacity of microbial test communities influences metrics for regulatory 212 
persistence assessment of chemicals derived from biotransformation kinetics in suspension 213 
tests (i.e., DegT50,TS and DT50,TS), we fitted a kinetic model to trajectories derived from those 214 
studies in which we observed significant compound removal, i.e., R1-Spring, R10-Fall, and 215 
CMP10 (SI2). A complete listing of all fit parameters and evaluation statistics is provided in 216 
SI8, Table SI6. Model fits were generally good with R2 greater than 0.8 for most evaluated 217 
trajectories. Sulfamethoxazole was the only compound for which dissipation clearly did not 218 
follow a lagged first-order decay (Figure SI1). Figure 2 presents lag phases, DegT50,TS, and 219 
DT50,TS for substances biotransformed in R1-Spring, R10-Fall, and CMP10.  220 
 221 
Figure 2. Lag phases, DegT50,TS, and DT50,TS of biotransformed substances in R1-Spring, R10-222 
Fall, and CMP10. Data for R1-Spring, R10-Fall, and CMP10 is colored in grey, orange, and 223 
red, respectively. Squares, diamonds and circles show an average value calculated from the 224 
experimental replicates, the error bars extend to the smallest and largest value found for the 225 
respective parameter, displayed as crosses. When lag phases exceeded the duration of the 226 
experiment, DegT50,TS could not be determined for the respective experimental replicate. 227 
When the lag phase exceeded the duration of the experiment in only one replicate, an average 228 
DegT50,TS was still calculated with the values from the remaining three replicates of R1-229 
Spring or CMP10. If lag phases exceeded the duration of the experiment in half of the 230 
replicates, no averaged DegT50,TS values are shown in this graph. Upwards pointing arrows in 231 
lag phase and DT50,TS data indicate that lag phases of at least one replicate exceeded the 232 
duration of the experiments and that the actual average as well as the actual maximum are 233 
higher than indicated in the graph. Compounds marked with asterisk were not included in the 234 
R10-Fall study. Note that the y-axis for the lag phases covers a different scale. 235 
 236 
Lag phases are commonly observed in laboratory biotransformation tests [16, 20, 45]; here, 237 
lag phases occurred to various extents for all compounds, except for bezafibrate, and ranged 238 
from ~1 day to up to more than 63 days, depending on compound and experiment. Lag phases 239 
in the same range were previously observed for several of our test compounds in various 240 
OECD biotransformation screening and simulation tests [16, 20, 45].  Here, lag phases were 241 
generally shorter in tests carried out with 10 g solids L-1, especially in CMP10. Further, we 242 
observed intra-test variations of lag phases, which were most significant in R1-Spring; 243 
differences between replicates were greater than 20 days for five compounds (i.e., acesulfame, 244 
bicalutamide, carbendazim, dimethenamid, and isoproturon). As discussed previously, 245 
biotransformation of at least three of those has been hypothesized to depend on the emergence 246 
of specific enzymes. 247 
However, current regulatory guidelines do not specify how to consider lag phases when 248 
assessing a substance’s persistence, i.e., whether DegT50 or DT50 are to be used as decisive 249 
persistence measure [9, 11, 32]. Since lag phases are a sign of microbial adaptation and 250 
reduced lag phases could be speculated for compounds continuously or repeatedly released to 251 
the aquatic environment (e.g., pharmaceuticals, pesticides, or certain industrial chemicals), it 252 
has been argued that DegT50 should be used as persistence metric [17, 21-23]. However, our 253 
experiments do not directly support this hypothesis as we determined shortest and least 254 
variable lag phases in suspensions employing a microbial community sourced from a pristine 255 
environment (CMP10). Therefore, and in light of the current lack of understanding of 256 
observed variability in lag phases, the use of DT50 values to assess persistence would seem the 257 
more cautious and environmentally protective approach. It needs to be noted though that 258 
DT50,TS of a given compound can range from a few days to over 100 days due to the combined 259 
effect of varying lag phases and DegT50,TS, see e.g., 5-methylbenzotriazole, carbendazim, 260 
diuron, or iprovalicarb in Figure 2/ Table SI6. Similarly, that variations in half-lives of one or 261 
two orders of magnitude have previously been observed in OECD 308 or OECD 309 studies 262 
for several of our test compounds, including acesulfame, diclofenac, trimethoprim, and 263 
venlafaxine, [16, 26, 46].     264 
To evaluate the effect of variable half-lives in a regulatory context, we performed an 265 
exemplary persistence assessment according to EMA and REACH criteria [9, 11]. Detailed 266 
assessment outcomes are provided in the Supporting Information (SI9). As expected from the 267 
significant differences between trajectories observed in various experiments and their 268 
replicates, persistence assessment outcomes were ambiguous for about half of the test 269 
compounds. Due to differences of up to two orders of magnitude in DegT50,TS and DT50,TS 270 
values, persistence assessment outcomes were not only ambiguous relative to the rather strict 271 
persistence criteria used in regulatory frameworks of the EU [9, 11], but also relative to higher 272 
persistence cut-off criteria used in other legislations, e.g., in the US [1].  273 
Environmental significance. The underlying assumption of persistence assessment based on 274 
laboratory simulation studies is that the outcomes reflect compound behavior in the 275 
environment [2, 7, 8]. To explore this assumption relative to our results, we compared them to 276 
two studies reporting concentration measurements of 12 of our test compounds along the 277 
Rhine (i.e., carbamazepine, cyclamate, diclofenac, isoproturon, lamotrigine, saccharin, 278 
sitagliptin, sulfamethoxazole, trimethoprim, and three confidential compounds) [27, 47]. In 279 
large streams, only compounds with half-lives in the range of the average travel time of all 280 
wastewater treatment plant inputs can be expected to show a clear dissipation signature. In 281 
case of the river Rhine, where wastewater treatment plants are distributed all along the river, 282 
this results in a low average travel time of approximately 7.7 days [47]. As a consequence, 283 
only substances with half-lives <10-20 days are significantly removed from the river Rhine. 284 
For sulfamethoxazole, sitagliptin, isoproturon, carbamazepine, cyclamate, diclofenac, 285 
lamotrigine, and one confidential compound, continuously increasing concentrations along the 286 
Rhine have been reported. While persistence classification based on our data was rather 287 
uncertain for the first three compounds, the latter five were indeed consistently classified as 288 
persistent (Table SI7). Trimethoprim was reported to be removed >80% along the Rhine [47]; 289 
accordingly, it was classified as non-persistent in most of our tests. Saccharin stood out in that 290 
it showed strong concentration fluctuations along certain parts of the Rhine [27]. This may 291 
result from industrial sources with effluent concentrations above typical municipal wastewater 292 
concentrations [48], but could also mean that biotransformation of saccharin depends on 293 
certain, spatially varying conditions. Indeed, considerable variations in lag phases and 294 
DegT50,TS for saccharin indicate that its removal is determined by specific microbiological 295 
conditions. The latter would suggest that variable outcomes from different suspension tests 296 
may be indicative of strong spatial and temporal fluctuations in biotransformation potential of 297 
a set compound in the aquatic environment where composition and activity of microbial 298 
communities also vary spatially and temporally [23, 28, 46, 49-51].  299 
Still, significant variations make the interpretation of biotransformation study outcomes 300 
challenging. It is therefore worth noting that we achieved most robust persistence 301 
classifications with a test system containing a 10-fold higher sediment content and at least 302 
three orders of magnitude higher bacterial cell densities than minimally required in the current 303 
OECD 309 guideline [8]. Our experimental results thus suggest that one approach to yield 304 
increased and more uniform biotransformation would be to increase bacterial cell densities 305 
and to provide sufficient nutrients in a test system. The fact that increased sediment content 306 
increased robustness of suspension test outcomes is also in line with low intra-study variations 307 
commonly observed in OECD 308 experiments [24, 46, 52], which employ water-sediment 308 
ratios of 3:1 or 4:1 (v/v) [7]. Alternatively, rather than trying to decrease variability in 309 
biotransformation tests, different data evaluation tools may allow to interpret test outcomes 310 
despite significant variations; in benchmarking, for example, test outcomes for a given 311 
compound would be assessed relative to a set of reference compounds with well-established 312 
environmental behavior [2]. We hope that further exploration of these emerging concepts will 313 
be facilitated with the rich set of biotransformation data that we present here.  314 
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